According to Bionomics's latest financial reports the company has $12.08 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-06-30 | $12.08 M | -64.01% |
2022-06-30 | $33.56 M | 56.75% |
2021-06-30 | $21.41 M | 580.7% |
2020-06-30 | $3.14 M | -69.19% |
2019-06-30 | $10.2 M | -45.85% |
2018-06-30 | $18.85 M | -43.51% |
2017-06-30 | $33.37 M | -2.88% |
2016-06-30 | $34.36 M | 65.21% |
2015-06-30 | $20.79 M | 110.35% |
2014-06-30 | $9.88 M | -51.76% |
2013-06-30 | $20.49 M | 15.47% |
2012-06-30 | $17.75 M | 3.42% |
2011-06-30 | $17.16 M | 61.76% |
2010-06-30 | $10.61 M | 176.67% |
2009-06-30 | $3.83 M | -36.26% |
2008-06-30 | $6.01 M | -45.4% |
2007-06-30 | $11.01 M | 213.76% |
2006-06-30 | $3.51 M | -39.84% |
2005-06-30 | $5.83 M | 3.47% |
2004-06-30 | $5.64 M | 43.37% |
2003-06-30 | $3.93 M | -29.35% |
2002-06-30 | $5.57 M | 605416.98% |
2001-06-30 | $0 M |